BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE | Published in Albany Law Review

Loading [Contrib]/a11y/accessibility-menu.js

Metrics
BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE

Lars Noah,

U.S. Food and Drug Administration“off-label” usesapproved therapeutic productsFirst Amendmentcommercial free speech principlesU.S. Supreme Courtbrand-name competitors

Pageviews and PDF downloads

Pageviews Downloads

0 past 90 days

Last 7 days Last 30 days Last 90 days All time

No results for selected time period